Why is Natraj Proteins Ltd falling/rising?

5 hours ago
share
Share Via
As of 19-Jan, Natraj Proteins Ltd’s stock price has declined by 2.01% to ₹30.27, continuing a downward trend driven by disappointing financial results and sustained underperformance relative to market benchmarks.




Recent Price Movement and Market Performance


On 19 January, Natraj Proteins Ltd recorded a price drop of ₹0.62, or 2.01%, closing at ₹30.27. This decline extends a two-day losing streak, during which the stock has fallen by approximately 2.04%. The stock’s performance today notably lagged behind its sector by 1.62%, signalling weaker investor sentiment relative to peers. Furthermore, the share is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained bearish momentum.


Investor participation has shown some signs of increased activity, with delivery volume on 16 January surging by over 850% compared to the five-day average. Despite this spike in volume, the stock remains vulnerable, as reflected in its continued price weakness.



From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!



  • - Early turnaround signals

  • - Explosive growth potential

  • - Textile - Machinery recovery play



Position for Explosive Growth →



Long-Term Underperformance Against Benchmarks


Over the past year, Natraj Proteins has delivered a negative return of 29.60%, a stark contrast to the Sensex’s positive 8.65% gain over the same period. This underperformance extends over longer horizons as well, with the stock declining by 46.33% over three years, while the Sensex rose by 36.79%. Even over five years, the stock’s 63.62% gain trails the benchmark’s 68.52% appreciation. Such consistent underperformance highlights the challenges the company faces in generating shareholder value relative to the broader market.


Fundamental Weaknesses and Financial Results


Despite an attractive valuation indicated by a Return on Capital Employed (ROCE) of 1% and an enterprise value to capital employed ratio of 0.6, the company’s fundamentals remain weak. Operating losses have persisted, with the latest quarterly results showing a PBDIT of negative ₹1.02 crore and an operating profit margin of -3.79%. Net sales for the nine months ended September 2025 declined by 23.59% to ₹76.54 crore, underscoring a contraction in business activity.


The company’s average Return on Equity (ROE) stands at a modest 6.97%, reflecting low profitability relative to shareholders’ funds. This weak profitability profile, combined with operating losses, undermines confidence in the company’s long-term financial health.


Valuation and Shareholding Structure


While the stock trades at a discount compared to its peers’ historical valuations, this has not translated into positive price momentum. The majority of shareholders are non-institutional, which may contribute to lower stability in shareholding patterns and potentially higher volatility. Notably, despite the stock’s negative price returns, reported profits have risen by 55.3% over the past year, suggesting some operational improvements that have yet to be reflected in the share price.



Holding Natraj Proteins from Edible Oil? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!



  • - Peer comparison ready

  • - Superior options identified

  • - Cross market-cap analysis



Switch to Better Options →



Conclusion: Why the Stock is Falling


The decline in Natraj Proteins Ltd’s share price as of 19 January is primarily driven by its sustained underperformance relative to market benchmarks and sector peers, coupled with weak financial results and operating losses. The stock’s failure to maintain levels above key moving averages signals continued bearish sentiment among investors. Although the company’s valuation metrics appear attractive and profits have increased, these positives are overshadowed by declining sales, low profitability, and a lack of institutional backing. Consequently, the market remains cautious, resulting in the stock’s ongoing price weakness.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News